UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

Casali, PG; Blay, JY; Abecassis, N; Bajpai, J; Bauer, S; Biagini, R; Bielack, S; ... Stacchiotti, S; + view all (2022) Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology , 33 (1) pp. 20-33. 10.1016/j.annonc.2021.09.005.

[thumbnail of ESMO-EURACAN-GENTURIS-GIST-Manuscript-Resubmission-Clean-TablesFiguresSupplementary.pdf] Text
ESMO-EURACAN-GENTURIS-GIST-Manuscript-Resubmission-Clean-TablesFiguresSupplementary.pdf - Accepted Version
Access restricted to UCL open access staff until 22 September 2022.

Download (516kB)

Abstract

Gastrointestinal stromal tumours (GISTs) are malignant mesenchymal tumours with a variable clinical behaviour, marked by differentiation towards the interstitial cells of Cajal. GISTs belong to the family of soft tissue sarcomas (STSs) but are treated separately due to their peculiar histogenesis, clinical behaviour and specific therapy. This European Society for Medical Oncology (ESMO)–European Reference Network for Rare Adult Solid Cancers (EURACAN)–European Reference Network for Genetic Tumour Risk Syndromes (GENTURIS) Clinical Practice Guideline (CPG) will cover GISTs while other STSs are covered in the ESMO–EURACAN–European Reference Network for Paediatric Oncology (ERN PaedCan)–GENTURIS STS CPG.

Type: Article
Title: Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
DOI: 10.1016/j.annonc.2021.09.005
Publisher version: https://doi.org/10.1016/j.annonc.2021.09.005
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
Keywords: GIST; clinical practice guidelines; gastrointestinal stromal tumour; surgery; tyrosine kinase inhibitor
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: https://discovery.ucl.ac.uk/id/eprint/10142481
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item